Excessive follicular response to controlled ovarian stimulation in a woman with menopausal FSH levels: case report. 2004

A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
Centre for Reproductive Medicine, St Bartholomew's Hospital and the London Hospitals Trust, London EC1A 7BE, UK.

A suspected poor responder to controlled ovarian stimulation (COS), with menopausal levels of follicular phase serum FSH, required coasting due to an excessive ovarian response. A 27 year old woman was referred to our Fertility Centre for ovum donation following repeated elevated, early follicular phase FSH levels (34.3, 27.1, 20.3 IU/l). Further investigations revealed the presence of antiovarian antibodies and a trial of COS, with the additional use of prednisolone, was proposed in view of her regular 28 day cycle. As 23 follicles were noted and an oestradiol level of 10,461 pmol/l following 7 days of stimulation with 450 IU of recombinant FSH per day, gonadotrophins were withheld for 9 days. Ten oocytes were retrieved and two grade I embryos were transferred. Pregnancy did not occur and she developed mild ovarian hyperstimulation syndrome. During a second cycle, multiple follicular development was again observed with an oestradiol level >13,200 pmol/l, despite a lower dose of gonadotrophin, and coasting was required for 4 days. Nineteen oocytes were collected, of which nine fertilized and cleaved. Two grade I embryos were replaced, leading to a singleton pregnancy. This patient subsequently had a vaginal delivery of a normal male baby at term. Young women with regular menstrual cycles and grossly elevated FSH levels may benefit from further investigation of autoantibodies and their ovarian response to exogenous gonadotrophins.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D008297 Male Males
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo
D005260 Female Females

Related Publications

A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
September 2022, Endocrinology,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
May 1996, The Journal of reproductive medicine,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
February 2000, Gynecologie, obstetrique & fertilite,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
March 1991, The Journal of reproductive medicine,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
October 2014, Journal of mid-life health,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
January 1967, Acta obstetricia et gynecologica Scandinavica,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
January 2023, Ginekologia polska,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
September 2020, Reproductive biology,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
May 1984, Acta endocrinologica,
A J Tozer, and T Al-Shawaf, and C M Y Gillott, and A M Lower, and J G Grudzinskas
January 2007, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!